According to WHO, approximately 6 million people worldwide die due to smoking cigarettes, which counts one death every 6 seconds
This review provides further justification for both varenicline and cytisine to become more widely available as soon as possible. Using studies from Cochrane Reviews, Lindson and colleagues evaluated 319 randomized controlled trials (RCTs), cluster-RCTs or factorial RCTs that included 157,179 participants and reported on rates of 6-month smoking cessation or longer to determine which smoking cessation intervention (varenicline, cytisine, nortriptyline, bupropion, NRT and e-cigarettes) is linked to the highest prevalence of quitting, as well as the smallest number of serious adverse events using Bayesian component network meta-analyses
This usually involves removing the data card and making some simple modifications
Buckner JD, Zvolensky MJ, Farris SG, Hogan J